Bosh sahifaDTIL • NASDAQ
add
Precision BioSciences Inc
Yopilish kursi
5,67 $
Kunlik diapazon
5,50 $ - 6,61 $
Yillik diapazon
3,53 $ - 8,82 $
Bozor kapitalizatsiyasi
155,78 mln USD
Oʻrtacha hajm
229,41 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 34,20 mln | 5 261,13% |
Joriy xarajat | 21,70 mln | -14,86% |
Sof foyda | 20,13 mln | 213,46% |
Sof foyda marjasi | 58,86 | 102,12% |
Har bir ulushga tushum | 1,01 | 147,09% |
EBITDA | 12,85 mln | 152,69% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 115,58 mln | 33,92% |
Jami aktivlari | 154,42 mln | 13,22% |
Jami passivlari | 62,17 mln | -22,29% |
Umumiy kapital | 92,25 mln | — |
Tarqatilgan aksiyalar | 24,73 mln | — |
Narxi/balansdagi bahosi | 1,48 | — |
Aktivlardan daromad | 25,23% | — |
Kapitaldan daromad | 37,49% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 20,13 mln | 213,46% |
Operatsiyalardan naqd pul | -11,25 mln | 39,78% |
Sarmoyadan naqd pul | -325,00 ming | -235,05% |
Moliyadan naqd pul | 77,52 mln | 1 209,39% |
Naqd pulning sof oʻzgarishi | 65,94 mln | 612,76% |
Boʻsh pul | 5,46 mln | 168,68% |
Haqida
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. Wikipedia
Tashkil etilgan
2006
Xodimlar soni
68
